Trials / Recruiting
RecruitingNCT07040202
Immune Responses to Dengue and Sepsis
Evaluating Immune Responses to Dengue and Sepsis in Hospitalized Patients in Cambodia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Institut Pasteur du Cambodge · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Accepted
Summary
The goal of this research study is to help the investigators better understand serious dengue disease. The investigators will collect clinical information and up to four blood samples from participants with dengue, sepsis, or healthy people. The investigators will perform multiple analyses on the blood samples and compare results between dengue patients and those with sepsis and healthy people.
Detailed description
This is an observational study enrolling n=200 hospitalized individuals with dengue-like illness, n=30 individuals with sepsis, and n=10 healthy controls to evaluate immune responses in plasma leak syndromes. Sepsis and dengue patients will have blood collected at enrollment, day 1, and day 3, and dengue patients will have an additional blood draw at day 21. Healthy participants will have a single blood draw at enrollment. The blood collected will enable the evaluation of immune kinetics, including changes in neutrophils, cytokines, and adaptive responses, as dengue progresses or improves. Overall, this study will facilitate the evaluation of an understudied cell type and will provide unique data for understanding the temporal changes in the immune response to dengue virus. A better understanding of dengue pathophysiology will help identify potential therapeutic targets to improve outcomes in this disease.
Conditions
Timeline
- Start date
- 2025-06-02
- Primary completion
- 2025-11-01
- Completion
- 2026-12-01
- First posted
- 2025-06-27
- Last updated
- 2025-06-27
Locations
3 sites across 1 country: Cambodia
Source: ClinicalTrials.gov record NCT07040202. Inclusion in this directory is not an endorsement.